BeOne Medicines
ONC
#649
Rank
A$53.83 B
Marketcap
A$486.51
Share price
-2.56%
Change (1 day)
49.97%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) Fails to deliver data

Key failure to deliver metrics for BeOne Medicines:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BeOne Medicines (ONC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BeOne Medicines (ONC) - since 2016

Volume in USD (price x number of shares), data since 2016

BeOne Medicines (ONC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$0.21 B151.73%
2024A$85.07 M104.8%
2023A$41.54 M-57.94%
2022A$98.76 M113.17%
2021A$46.33 M-62.37%
2020A$0.12 B40.02%
2019A$87.92 M48.77%
2018A$59.1 M255.99%
2017A$16.6 M169.67%
2016A$6.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Onconova Therapeutics
ONTX
A$0.06 MA$0.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A$0.07 MA$7.56 M๐Ÿ‡บ๐Ÿ‡ธ USA